OT-551

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2015
0120072015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Nitroxide small molecule agents are in development as preventative or therapeutic pharmaceutical drugs for age-related macular… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2013
Review
2013
Age-related macular degeneration (ARMD) is the leading cause of irreversible blindness in developed countries. There are… (More)
Is this relevant?
2010
2010
OT-551 (1-hydroxy-4-cyclopropanecarbonyloxy-2,2,6,6-tetramethylpiperidine hydrochloride), is a novel small molecule with… (More)
Is this relevant?
Review
2010
Review
2010
PURPOSE To investigate the safety and preliminary efficacy of OT-551, a disubstituted hydroxylamine with antioxidant properties… (More)
Is this relevant?
Review
2009
Review
2009
As researchers and clinicians are beginning to understand that wet age-related macular degeneration (AMD) is more than simply a… (More)
Is this relevant?
2007
2007
PURPOSE OT-551 (1-hydroxy-4-cyclopropanecarbonyloxy-2,2,6,6-tetramethylpiperidine hydrochloride), a TEMPOL-H (OT-674) derivative… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?